Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors-There is hope, but more data are needed
J Surg Oncol
.
2020 Sep;122(3):572.
doi: 10.1002/jso.25972.
Epub 2020 May 17.
Authors
James R Barrett
1
,
Daniel E Abbott
1
Affiliation
1
Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin.
PMID:
32419171
DOI:
10.1002/jso.25972
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Intestinal Neoplasms*
Neuroendocrine Tumors*
Pancreatic Neoplasms*
Stomach Neoplasms*
Grants and funding
T32CA090217/Surgical Oncology T32 Grant/International